Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Welin, Lennart ^a,b   Adlerberth, Annika ^b   Caidahl, Kenneth ^b,d   Eriksson, Henry ^b   Hansson, Per Olof ^b   Johansson, Saga ^c   Rosengren, Annika ^b   Svärdsudd, Kurt ^e   Welin, Catharina ^b   Wilhelmsen, Lars ^b  

^a Lidkoping Hospital   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLASSIFICATION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; HYPERTENSION; LIFESTYLE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SWEDEN;

BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEYS; HUMANS; HYPERTENSION; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; RISK-TAKING; SMOKING; SWEDEN;

EID: 58249100084     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-403     Document Type: Article

References (31)

1. Epidemiological approaches to heart disease. The Framingham study. TR Dawber GF Meadors FE Moore, Am J Public Health 1951 41 279 286 10.2105/AJPH.41.3.279
2. High blood pressure in men aged 50 - a population study of men born in 1913. G Tibblin, Acta Med Scand Suppl 1967 470 1 84 5231221
3. Obesity. A population study of men, with special reference to development and consequences for the health. B Larsson, PhD thesis Göteborg University 1978
4. Why is the incidence of ischaemic heart disease in Sweden increasing? The study of men born in 1913 and 1923. L Welin B Larsson K Svärdsudd L Wilhelmsen G Tibblin, Lancet 1983 14 1087 1089 10.1016/S0140-6736(83)91920-7
5. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. A Rosengren L Wilhelmsen L Welin A Tsipogianni AC Teger-Nilsson H Wedel, BMJ 1990 300 634 638 2322698
6. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765
7. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 499 501 4337382
8. Social network and activities in relation to mortality from cardiovascular diseases, cancer and other causes: a 12 year follow up of the Study of Men Born in 1913 and 1923. L Welin B Larsson K Svärdsudd B Tibblin G Tibblin, J Epidemiol Comm Health 1992 46 127 132 10.1136/jech.46.2.127
9. Independent importance of psychosocial factors for prognosis after myocardial infarction. C Welin G Lappas L Wilhelmsen, J Intern Med 2000 247 629 639 10.1046/j.1365-2796.2000.00694.x 10886484
10. SAS system 8.2, SAS Institute Inc., Cary, NC, USA
11. Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO consulatation. WHO, Part I: Diagnosis and classification of diabetes mellitus. Geneva 1999
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
13. The metabolic syndrome - a new worldwide definition. KG Alberti P Zimmet J Shaw IDF Epidemiology Task Force Consensus Group, Lancet 2005 366 1059 1062 10.1016/S0140-6736(05)67402-8 16182882
14. Risk factors for cardiovascular disease during the period 1985-1995 in Göteborg, Sweden. The GOT-MONICA Project. L Wilhelmsen S Johansson A Rosengren I Wallin A Dotevall G Lappas, J Intern Med 1997 242 199 211 10.1046/j.1365-2796.1997.00163.x 9350164
15. The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. G Tibblin L Welin B Larsson IL Ljungberg K Svärdsudd, Scand J Soc Med 1982 10 27 32 7112052
16. Nonparticipants in a general population study of men, with special reference to social and alcoholic problems. A Rosengren L Wilhelmsen G Berglund D Elmfeldt, Acta Med Scand 1987 221 243 251 3591462
17. MONICA Monograph and Multimedia Sourcebook. H Tunstall-Pedoe Ed, World Health Organisation, Geneva 2003
18. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. CM Berg L Lissner N Aires G Lappas K Torén L Wilhelmsen A Rosengren DS Thelle, Eur J Cardiovasc Prev Rehabil 2005 12 115 125 10.1097/00149831-200504000-00005 15785296
19. Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. L Getz JA Sigurdsson I Hetlevik AL Kirkengen S Romundstad J Holmen, BMJ 2005 331 551 554 16103030 10.1136/bmj.38555.648623.8F
20. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. B Hildrum A Mykletun T Hole K Midthjell AA Dahl, BMC Public Health 2007 7 220 17727697 10.1186/1471-2458-7-220
21. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. W Rathmann B Haastert A Icks G Giani R Holle W Koenig H Löwel C Meisinger, Diabetes Care 2006 29 461 10.2337/diacare.29.02.06.dc05- 1885 16443909
22. Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary health care: The German metabolic and cardiovascular risk project (GEMCAS). S Moebus JU Hanisch P Aidelsburger P Bramlage J Wasem K-H Jöckel, Cardiovascular Diabetology 2007 6 22 17822558 10.1186/1475-2840-6-22
23. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. VG Athyros ES Ganotakis MS Elisaf EN Liberopoulos IA Goudevenos A Karagiannis, Int J Cardiol 2007 117 204 210 10.1016/j.ijcard.2006.04.078 16854482
24. Prevalence of the metabolic syndrome and overweight among adults in China. D Gu K Reynolds X Wu J Chen X Duan RF Reynolds PK Whelton J He, Lancet 2005 365 1398 1405 10.1016/S0140-6736(05)66375-1 15836888
25. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. F Harzallah H Alberti FB Khalifa, Diabetic Medicine 2006 23 441 444 10.1111/j.1464-5491.2006.01866.x 16620275
26. The myth of the metabolic syndrome. EAM Gale, Diabetologia 2005 48 1679 1883 10.1007/s00125-005-1873-5 16025251
27. The metabolic syndrome: time for a critical appraisal. R Kahn E Ferrannini J Buse M Stern, Diabetologia 2005 48 1684 1699 10.1007/s00125-005- 1876-2 16079964
28. Should we dump the metabolic syndrome? EAM Gale, BMJ 2008 336 640 18356231 10.1136/bmj.39477.500197.AD
29. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. N Sattar A McConnachie AG Shaper GJ Blauw BM Buckley AJ de Craen I Ford NG Forouhi DJ Freeman JW Jukema L Lennon PW Macfarlane MB Murphy C Packard DJ Stott RG Westendorp PH Whincup J Shepherd SG Wannamethee, Lancet 2008 371 1927 1935 10.1016/S0140-6736(08)60602-9 18501419
30. Metabolic syndrome - what is the clinical usefulness? R Kahn, Lancet 2008 371 1892 1893 10.1016/S0140-6736(08)60731-X 18501420
31. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. J Sundström U Risérus L Byberg B Zethelius H Lithell L Lind, BMJ 2006 332 878 882 16510492 10.1136/bmj.38766.624097.1F